Overall, these results suggest that chrysophanol targets NF-κB/Bcl-2 to suppress BC cell proliferation and enhance sensitivity to chemotherapy, potentially serving as a valuable chemotherapeutic agent against BC cells [80]. The gene discussed is NFKB1; the disease is breast cancer.